Oric Pharmaceuticals
Brian Newfield has a strong background in finance and has held various roles in the industry. Brian is currently working at ORIC Pharmaceuticals Inc. as the Sr. Director Finance FP&A. Prior to this, they worked at Prometheus Laboratories Inc., A Nestlé Health Science Company as the Finance Director - Co-Pilot R&D and Diagnostics Operations from 2013 to 2019. Brian also has experience working at Nestlé Health Science and Nestlé Nutrition North America (Gerber) in finance-related roles. Additionally, they have worked at Novartis as a Finance Manager and Senior Financial Analyst, and at John G. Kinnard & Co. as an Investment Banking Analyst.
Brian Newfield completed their Bachelor of Accounting degree at the University of Minnesota Duluth. Brian then pursued further education at the University of Minnesota - Carlson School of Management, where they obtained a Masters of Business Administration (MBA) specializing in Strategic Management from 2000 to 2002.
This person is not in any offices
Oric Pharmaceuticals
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline targets other undisclosed mechanisms of oncology therapy resistance. ORIC's scientific founders are Drs. Charles Sawyers, MD, and Scott Lowe, PhD, who have strong records of discovering innovative treatments and targets in cancer. The company has assembled strong leadership and scientific teams and a board with extensive experience in drug development and financing. ORIC is funded by leading biotechnology investors, including The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company, Trinitas Capital, Foresite Capital, Taiho Ventures, Memorial Sloan Kettering, Kravis Investment Partners, NS Investment and City Hill Ventures. ORIC is headquartered in South San Francisco, California.